血小板活性化因子アセチルヒドロラーゼ機能調整剤

Platelet-activating factor acetylhydrolase function regulator

Abstract

PROBLEM TO BE SOLVED: To provide a means for letting a platelet-activating factor acetylhydrolase reach quickly to a biomembrane and specifically removing a peroxidized site of phospholipid which is a constituting component of the biomembrane. SOLUTION: This platelet-activating factor acetylhydrolase function regulator contains andrographolide as an active ingredient. The skin preparation for external use and composition for oral administration containing the same are also provided. COPYRIGHT: (C)2007,JPO&INPIT
【課題】 血小板活性化因子アセチルヒドロラーゼを速やかに生体膜に到達させ、生体膜の構成成分であるリン脂質の過酸化された部位を特異的に取り除くことができる手段を提供すること。 【解決手段】 アンドログラホリドを有効成分とする血小板活性化因子アセチルヒドロラーゼ機能調整剤並びにこれを含有する皮膚外用剤および経口用組成物。 【選択図】 なし

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (9)

    Publication numberPublication dateAssigneeTitle
    JP-2001322948-ANovember 20, 2001Kose Corp, 株式会社コーセー血小板活性化因子アセチルハイドロラーゼ活性調整剤及びこれを配合する皮膚外用剤
    JP-2002121112-AApril 23, 2002Nonogawa Shoji Kk, 有限会社野々川商事皮膚外用剤
    JP-2003516950-AMay 20, 2003エイボン プロダクツ インコーポレーテッド細胞対細胞の連絡を仲介するスキンケア組成物
    JP-2003522166-AJuly 22, 2003ドクター・レディーズ・ラボラトリーズ・リミテッド抗腫瘍活性を有する化合物:その製法およびそれを含有する医薬組成物
    JP-H0930946-AFebruary 04, 1997Shiseido Co Ltd, 株式会社資生堂Beautifying and whitening dermal preparation for external use
    JP-H1029927-AFebruary 03, 1998Shiseido Co Ltd, 株式会社資生堂Antiaging agent
    WO-2005074953-A1August 18, 2005Universidad Austral De Chile, Körber, MartinComposition de diterpenes du type labdane extraite de andrographis paniculata, utilisee pour traiter les maladies auto-immunes et la maladie d'alzheimer par activation des recepteurs ppr-gamma
    WO-2005087223-A1September 22, 2005Hutchison Medipharma Ltd.L'andrographolide et ses analogues inhibiteurs de l'expression du tnf$g(a) et de l'il-1$g(b)
    WO-2005104722-A2November 10, 2005Hutchison Medipharma Enterprises LimitedCrude extracts from andrographis paniculata

NO-Patent Citations (3)

    Title
    JPN6012035001; GUPTA S.: 'Antioxidants: Formulation of Cosmetic Delivery Systems.' Househ Pers Prod Ind 38(7), 2001, p.56-61
    JPN6012035002; SHEN,Y.C. et al: 'Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) invol' Br J Pharmacol Vol.135, No.2, 2002, p.399-406
    JPN6012035003; XIA,Y.F. et al: 'Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modi' J Immunol Vol.173, No.6, 2004, p.4207-17

Cited By (9)

    Publication numberPublication dateAssigneeTitle
    CN-102382083-AMarch 21, 2012天津天士力现代中药资源有限公司Preparation method of andrographolide
    CN-102382083-BJuly 15, 2015天津天士力现代中药资源有限公司Preparation method of andrographolide
    CN-103145658-AJune 12, 2013江西青峰药业有限公司17-氢-9-去氢穿心莲内酯-3-硫酸酯钠(或钾)、17-氢-9-去氢穿心莲内酯-19-硫酸酯钠(或钾)、17-氢-9-去氢穿心莲内酯-3,19-二硫酸酯钠(或钾)组合物的一次制备方法及其制备药物用途
    EP-2411004-A1February 01, 2012National University of SingaporeUse of andrographolide compounds for treating inflammation and airway disorders
    EP-2411004-A4August 15, 2012Univ SingaporeUtilisation de composés andrographolides dans le traitement des inflammations et des troubles des voies respiratoires
    GB-2464813-AMay 05, 2010Univ SheffieldTreatments for neurodegenerative disorders
    US-8507547-B2August 13, 2013Suntory Holdings LimitedAnti-fatigue agents and oral compositions containing andrographolide as active ingredient
    WO-2008149802-A1December 11, 2008Suntory Holdings Limitedアンドログラホリドを有効成分とする抗疲労剤及び経口組成物
    WO-2010046710-A1April 29, 2010University Of SheffieldAgents thérapeutiques contre des troubles neurologiques